Table 1 Baseline characteristic of study patients

Number of eyes

17

Age, years

67.2 ± 9.9

Sex, men/women

12/2

Type of diabetes, Type 1 / Type 2, n

6/11

Diabetic retinopathy stage, NPDR/PDR, n

16/1

Duration of suffering diabetes, years

12.3 ± 9.4

Duration of macular edema, years

2.9 ± 2.5

HbA1c (%)

7.6 ± 1.1

BCVA (log MAR)

0.44 ± 0.31

Central retinal thckness (µm)

458.7 ± 115.1

Central retinal sensitivity (dB)

16.9 ± 7.6

peudophakic, n

3

Panretinal photocoagulation, n

7

Prior treatment for DME, n

 Intravitreal anti-VEGF

3

 Sub-Tenon’s injection of triamcinolone acetonide

9

 Photocoagulation

6